3Carmina E.Dignosis of polycystic ovary syndrome:from NIH criteria to ESHRE-ASR M guidelines[J].Minerva Ginecol,2004,56(1):1-6.
4Gaasenbeek M,Powell BL,Sovio U,Haddad L,et al.Large-scale analysis of the relationship between CYP11A promoter variation,polycystic ovarian syndrome,and serum testosterone[J].J Clin Endocrinol Metab,2004 May,89(5):2408-2413.
5Tong Y,Liao WX,Roy AC,et al.Association of ACCI polymorphism in the follicle-stimulating hormone beta gene with polycystic ovary syndrome[J].Fertil Steri1,2000,74:1233-1236.
7Kalro BN,Loucks TJ,Berqa SL.Neuron odulation in polycystic ovary syndrome[J].Obstet Gynecol Clin North Am,2001,28(1):35-62.
8Dunaif A.Hyperandrogenic anovulation(PCOS):a uniquic disorder insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus[J].Am J Med,1995,98(Suppl):33-39.
9Tapanainen JS,Koivunen R,Fauser BC,et al.A new contributing factor to polycystic ovary syndrome:the genetic variant of luteinizing hormone[J].J Clin Endocrinol Metab,1999,84:1711-1715.
10Ciaraldi TP,Morales AJ,Asscheman MG,et al.Lack of insulin resistance in fibroblasts from subjects with polycystie ovary syndrome[J].Metabolism,1998,47(8):940-946.
